Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Athira Pharma, Inc. (LONA) had Income from Continuous Operations of $-96.94M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-96.94M |
|
-- |
|
-- |
|
$100.90M |
|
$-100.90M |
|
$3.96M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
|
Income from Continuous Operations |
$-96.94M |
$-96.94M |
|
$-96.94M |
|
$-100.90M |
|
$-100.45M |
|
3.85M |
|
3.85M |
|
$-25.20 |
|
$-25.20 |
|
| Balance Sheet Financials | |
$54.84M |
|
$2.44M |
|
$3.94M |
|
$58.78M |
|
$13.13M |
|
-- |
|
$0.80M |
|
$13.94M |
|
$44.84M |
|
$44.84M |
|
$44.84M |
|
3.90M |
|
| Cash Flow Statement Financials | |
$-97.17M |
|
$54.83M |
|
$0.19M |
|
$91.22M |
|
$49.07M |
|
$-42.15M |
|
$11.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-97.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-216.19% |
|
-216.19% |
|
-164.92% |
|
-216.19% |
|
$11.49 |
|
$-25.26 |
|
$-25.25 |
|